Ipamorelin
A selective pentapeptide ghrelin receptor agonist studied in preclinical models for GH-axis modulation without significant cortisol or prolactin stimulation.
Available formats
3ml vial — 5mg/ml (15mg total)
IPAM-3ML-5MG
5ml vial — 5mg/ml (25mg total)
IPAM-5ML-5MG
To place a research order, contact info@paradisecompounds.com.
Chemical Identity
| CAS Number | 170851-70-4 |
|---|---|
| Molecular Formula | C38H49N9O5 |
| Molecular Weight | 711.85 g/mol |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Appearance | White lyophilized powder |
| Storage | Lyophilized: -20°C. Reconstituted: refrigerated, use within 30 days. |
Certificates of Analysis
Batch PLACEHOLDER-2026-A
Lot PC-IPAM-2026-001 · Janoshik Analytical · 1/14/2026
99.1%
purity
Research Notes
Ipamorelin is a synthetic pentapeptide and growth hormone secretagogue (GHS) that selectively binds the ghrelin/GHS-R1a receptor.
Research interest
Ipamorelin has been investigated in preclinical models for:
- Selective growth hormone release with minimal effect on cortisol, prolactin, or aldosterone
- Comparison studies against other ghrelin mimetics (GHRP-2, GHRP-6, hexarelin)
- Pulsatile GH-axis signaling in animal models
References
- PubMed query for Ipamorelin
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998.
This product is sold for laboratory and research use only. It is not intended for human consumption, in vitro diagnostic use, therapeutic use, or veterinary use.
All products sold on this site are intended strictly for laboratory and research use only. They are NOT intended for human consumption, in vitro diagnostic use, therapeutic use, or veterinary use. By purchasing from Paradise Compounds, you affirm that you are a qualified researcher and agree to use these materials in accordance with all applicable federal, state, and local laws.